Accretive Acquisition of Sanity Group Establishes Organigram as a Global Pure Play Cannabis Company with Leadership Positions in the World's Two Largest Federally Legal Cannabis Markets

• Organigram to acquire Sanity Group for up-front consideration of €113.4 million plus a maximum earnout of up to €113.8 million tied to financial performance.
• Proposed Acquisition of the Berlin‑based company unites two leaders in the largest federally legal cannabis markets, boosting commercial opportunities, strengthening access to best‑in‑class leadership, and expanding a valuable network of supply-chain partners.
• Sanity is achieving top-line growth. Annual net revenue increased from €9 million in 2023 to €60 million in 2025, including €19 million generated in the fourth quarter of 2025.
• Sanity Group operates Europe's first two legal cannabis specialty stores as part of scientific pilot projects in Switzerland.
• Opportunity to capitalize on Sanity's near-term plans to enter the UK and Poland markets and expand on existing business in Czechia.
• Opportunity to bring industry-leading IP generated by the Product Development Collaboration (PDC) as well as Organigram's products to emerging legal cannabis markets.
• Organigram poised to sell significantly greater volumes of higher-margin flower into Europe with the ability to capture more of the value chain.
• Acquisition is expected to be financed by a combination of cash on hand, proceeds from a new credit facility, and expected C$65.2 million equity investment by BAT.